BioTek Instruments, Inc. Develops Automation Technology to Aid in Blood Banking Tests

BioTek Instruments, a leader in microplate instrumentation technology, has developed in partnership with Immucor, Inc. (Norcross, GA), an automated benchtop assay instrument for use in the blood transfusion industry.

Manufactured by BioTek exclusively for Immucor, the Galileo^® Echo™ provides small- to medium-sized hospital blood bank laboratories with walk-away automation of tests such as ABO grouping and Rh (D) typing, detection/identification of IgG red blood cell antibodies, compatibility testing and red blood cell phenotyping for significant increases in productivity and patient safety while taking less time than other methods.

The Galileo Echo instrument was recently cleared by the FDA for marketing in the United States, and also received a CE mark, along with its associated reagents, for distribution in Europe. "Immucor and BioTek have forged a strong partnership for over fifteen years, which is key to producing beneficial products that seamlessly fuse our respective skills and expertise," noted Adam Alpert, Vice President of BioTek Instruments. "We congratulate Immucor on the recent clearance of the Galileo Echo system, and we look forward to the results of our mutually successful projects."